Ali Oku
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ali Oku has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Heather Geiger
New York Genome Center, New York, NY, USA
3 shared publications - Nicolas Robine
New York Genome Center, New York, NY, USA
3 shared publications - Rui Fu
New York Genome Center, New York, NY, USA
2 shared publications Aaron Nizam
Cold Spring Harbor Laboratory
1 shared publication- Alex Tokolyi
New York Genome Center, New York, NY, USA
1 shared publication Alexander Krasnitz
Cold Spring Harbor Laboratory
1 shared publication
Latest Publications
- Open Access
DECONVersation: Single-Cell Foundation Model-Derived Embeddings for Robust Cell Type Deconvolution of Bulk RNA-seq
Motivation: Bulk RNA-seq deconvolution uses single-cell references to estimate cell type proportions in bulk tissue. Existing methods face challenges with batch effects, subject-level variation, and marker gene selection. We propose a new approach leveraging general-purpose single-cell foundation models. Results: DECONVersation combines pretrained or fine-tuned single-cell foundation model embeddings with non-negative least squares for deconvolution. The embeddings eliminate the need for explicit marker selection, and reduce batch effects. Compared against MuSiC, DWLS, and BayesPrism, DECONVersation with Geneformer or Cell2Sentence-2B achieved competitive performance across six bulk datasets with ground truth, with performance improvements after reference-specific fine-tuning. Availability and Implementation: DECONVersation is available through the Python Package Index. The source code is available at https://github.com/nygenome/DECONVersation , and the datasets and Apptainer/Singularity images are archived on https://zenodo.org/records/22949405 . Contact: rfu@nygenome.org Supplementary information: Supplementary data are available online.
Open AccessDECONVersation: Single-Cell Foundation Model-Derived Embeddings for Robust Cell Type Deconvolution of Bulk RNA-seq
Motivation: Bulk RNA-seq deconvolution uses single-cell references to estimate cell type proportions in bulk tissue. Existing methods face challenges with batch effects, subject-level variation, and marker gene selection. We propose a new approach leveraging general-purpose single-cell foundation models. Results: DECONVersation combines pretrained or fine-tuned single-cell foundation model embeddings with non-negative least squares for deconvolution. The embeddings eliminate the need for explicit marker selection, and reduce batch effects. Compared against MuSiC, DWLS, and BayesPrism, DECONVersation with Geneformer or Cell2Sentence-2B achieved competitive performance across six bulk datasets with ground truth, with performance improvements after reference-specific fine-tuning. Availability and Implementation: DECONVersation is available through the Python Package Index. The source code is available at https://github.com/nygenome/DECONVersation , and the datasets and Apptainer/Singularity images are archived on https://zenodo.org/records/22949405 . Contact: rfu@nygenome.org Supplementary information: Supplementary data are available online.
- Open Access
Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally-Diverse Cohort
Endometrial cancer (EC) exhibits one of the most striking racial disparities in oncology with black women disproportionately affected by aggressive high-grade subtypes that have poorer outcomes. While social and environmental factors undoubtedly contribute, the molecular underpinnings of these disparities remain critically understudied. To bridge this knowledge gap, we performed matched tumor-normal whole-genome sequencing and tumor transcriptome sequencing on 71 predominantly high-grade EC patient samples from an ancestrally diverse cohort of women recruited at a large hospital system in the New York metropolitan area. Our analysis characterized the germline and somatic mutation landscape, identifying ancestry-associated molecular differences. Notably, focal amplification of the EVI1 transcription factor (encoded at the MECOM locus) was significantly more frequent in African ancestry patients and associated with poorer clinical outcomes in an external validation cohort. Additionally transcriptome analysis revealed decreased CD8+ T cell infiltration with increasing African ancestry, suggesting tumor immune microenvironment differences with potential therapeutic implications.
Open AccessComprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally-Diverse Cohort
Endometrial cancer (EC) exhibits one of the most striking racial disparities in oncology with black women disproportionately affected by aggressive high-grade subtypes that have poorer outcomes. While social and environmental factors undoubtedly contribute, the molecular underpinnings of these disparities remain critically understudied. To bridge this knowledge gap, we performed matched tumor-normal whole-genome sequencing and tumor transcriptome sequencing on 71 predominantly high-grade EC patient samples from an ancestrally diverse cohort of women recruited at a large hospital system in the New York metropolitan area. Our analysis characterized the germline and somatic mutation landscape, identifying ancestry-associated molecular differences. Notably, focal amplification of the EVI1 transcription factor (encoded at the MECOM locus) was significantly more frequent in African ancestry patients and associated with poorer clinical outcomes in an external validation cohort. Additionally transcriptome analysis revealed decreased CD8+ T cell infiltration with increasing African ancestry, suggesting tumor immune microenvironment differences with potential therapeutic implications.
- Open Access
The New York Genome Center ALS Consortium resource integrates postmortem tissue transcriptomics and whole genome sequencing to empower biological discovery
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with substantial genetic and clinical heterogeneity that impedes therapeutic development. Large-scale multi-tissue genomic resources have transformed the study of neuropsychiatric and neurodegenerative diseases, but no equivalent resource exists for ALS. Here we present the full NYGC ALS Consortium dataset, combining whole-genome sequencing from 4,746 donors and bulk RNA-seq from 2,574 samples across 8 brain and spinal cord regions from 695 donors across the ALS disease spectrum. Our catalogue of small variants, structural variants, and short tandem repeats identified likely pathogenic mutations in 15.6% of ALS cases. Gene expression and mRNA splicing analysis across 5 major tissues reveals shared and region-specific features, highlighting microglial and T-cell dysregulation in the spinal cord. Mapping the genetic regulation of expression and splicing across tissues identified associations with 6 ALS risk loci, whereas allele-specific rare variant analysis detected expression effects for C9orf72 and OPTN . All data are immediately publicly available.
Open AccessThe New York Genome Center ALS Consortium resource integrates postmortem tissue transcriptomics and whole genome sequencing to empower biological discovery
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with substantial genetic and clinical heterogeneity that impedes therapeutic development. Large-scale multi-tissue genomic resources have transformed the study of neuropsychiatric and neurodegenerative diseases, but no equivalent resource exists for ALS. Here we present the full NYGC ALS Consortium dataset, combining whole-genome sequencing from 4,746 donors and bulk RNA-seq from 2,574 samples across 8 brain and spinal cord regions from 695 donors across the ALS disease spectrum. Our catalogue of small variants, structural variants, and short tandem repeats identified likely pathogenic mutations in 15.6% of ALS cases. Gene expression and mRNA splicing analysis across 5 major tissues reveals shared and region-specific features, highlighting microglial and T-cell dysregulation in the spinal cord. Mapping the genetic regulation of expression and splicing across tissues identified associations with 6 ALS risk loci, whereas allele-specific rare variant analysis detected expression effects for C9orf72 and OPTN . All data are immediately publicly available.